Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

This publication has 32 references indexed in Scilit:

• Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
  New England Journal of Medicine, 1998
• A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
  Head & Neck, 1997
• 59: Protection of salivary glands by amifostine in patients treated with high dose radioiodine
  European Journal Of Cancer, 1997
• Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors
  Cancer, 1997
• Povidone-Iodine to Prevent Mucositis in Patients during Antineoplastic Radiochemotherapy
  Dermatology, 1997
• The Effect of Overall Treatment Time of Radiation Therapy on Local Control of T1‐Stage Squamous Call Carcinoma of the Glottis
  The Laryngoscope, 1996
• Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck
  JNCI Journal of the National Cancer Institute, 1996
• Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal Cancer
  Acta Oncologica, 1994
• Pharmacokinetics of WR-2721
  Pharmacology & Therapeutics, 1988